Dr. Kwatra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 N Caroline St Ste 8065
Baltimore, MD 21287Phone+1 410-955-5933Fax+1 410-502-2309
Education & Training
- Johns Hopkins UniversityResidency, Dermatology, 2012 - 2015
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2012
- Duke UniversityBS
Certifications & Licensure
- MD State Medical License 2017 - 2026
- IL State Medical License 2012 - 2013
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 71 citationsA constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomasToshimasa Akazawa, Shawn G. Kwatra, Laura E. Goldsmith, Mark D. Richardson, Elizabeth A. Cox
Journal of Neurochemistry. 2009-05-01 - 34 citationsAtopic dermatitis is associated with increased prevalence of multiple ocular comorbidities.Kishan Govind, Katherine A. Whang, Raveena Khanna, Adrienne W. Scott, Shawn G. Kwatra
The Journal of Allergy and Clinical Immunology. in Practice. 2019-01-01 - 36 citationsDiagnostic Workup and Evaluation of Patients with Prurigo Nodularis.Christina D. Kwon, Raveena Khanna, Kyle A. Williams, Madan M. Kwatra, Shawn G. Kwatra
Medicines. 2019-09-26
Journal Articles
- Itching at Night: A Review on Reducing Nocturnal Pruritus in ChildrenEmily Boozalis, Bernard A Cohen, Anna L Grossberg, Shawn G Kwatra, Katherine B Puttgen, Pediatric Dermatology
Press Mentions
- New Drug Class for Prurigo Nodularis Moving ForwardOctober 7th, 2024
- Once Considered Rare, an Itchy Dermatologic Skin Disorder Is More Common Than ThoughtAugust 26th, 2019
- Proposing a Stratification Scheme for Chronic Pruritus of Unknown Origin Nomenclature Based on Presence of Eosinophilia: Implications for Therapeutics and Cohort Homogeneity for Clinical TrialsJuly 29th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: